Skip to main content

letter

. 2008 Dec 20;40(8):430–431. [Article in Spanish] doi: 10.1157/13125415

Úlcera oral crónica por ingestión de alendronato

Francisco Cardona Tortajada ¹, Esther Sainz Gómez ¹, Jorge Figuerido Garmendia ¹, Ana Lirón de Robles Adsuar ¹

PMCID: PMC7713416 PMID: 18755110

The content is available as a PDF (115.3 KB).

Bibliografía

1.Selby P. Alendronate treatment for osteoporosis: a review of the clinical evidence. Osteoporos Int. 1996;6:419–426. doi: 10.1007/BF01629572. [DOI] [PubMed] [Google Scholar]
2.Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo de medicamentos. Colección Consejo Plus 2007.Tomo I. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2007.
3.Demerjian N., Bolla G., Spreux A. Severe oral ulcerations induced by alendronate. Clin Rheumatol. 1999;18:349–350. doi: 10.1007/s100670050116. [DOI] [PubMed] [Google Scholar]
4.González-Moles M.A., Bagan-Sebastián J.V. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med. 2000;29:514–518. doi: 10.1034/j.1600-0714.2000.291006.x. [DOI] [PubMed] [Google Scholar]
5.Krasagakis K., Kruger-Krasagakis S., Ioannidou D., Tosca A. Chronic erosive and ulcerative oral lesions caused by incorrect administration of alendronate. J Am Acad Dermatol. 2004;50:651–652. doi: 10.1016/j.jaad.2003.07.030. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES